Meyer Balter

Meyer Balter's AcademicInfluence.com Rankings

Meyer Balter

Philosophy

#12750

World Rank

#17794

Historical Rank

Logic

#9691

World Rank

#12326

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Meyer Balter Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Meyer Stanley Balter, MD, FRCPC, FACP, FCCP is a Canadian physician specializing in asthma, sarcoidosis and chronic obstructive pulmonary disease . He earned an M.D. from McGill University Faculty of Medicine . He became a Fellow of the Royal College of Physicians and Surgeons of Canada in 1989. He currently is Director, Asthma Education Clinic and Director, Internal Medicine Residency Training Program at Mount Sinai Hospital , and Professor of Medicine, University of Toronto.

(See a Problem?)

Meyer Balter's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. (2007) (683)
Tiotropium in Combination with Placebo, Salmeterol, or FluticasoneSalmeterol for Treatment of Chronic Obstructive Pulmonary Disease (2007) (399)
Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease--2003. (2003) (328)
Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline. (2015) (270)
Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline. (2011) (233)
Adult Asthma Consensus Guidelines update 2003. (2004) (188)
Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care. (2008) (171)
Canadian guidelines for the management of acute exacerbations of chronic bronchitis. (2003) (140)
Optimizing pulmonary rehabilitation in chronic obstructive pulmonary disease--practical issues: a Canadian Thoracic Society Clinical Practice Guideline. (2010) (129)
Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force. (2011) (129)
Large airway disease associated with inflammatory bowel disease. (1998) (115)
State of the Art Compendium: Canadian Thoracic Society recommendations for the management of chronic obstructive pulmonary disease. (2004) (110)
Counting, analysing and reporting exacerbations of COPD in randomised controlled trials (2007) (109)
Alpha-1 antitrypsin deficiency targeted testing and augmentation therapy: a Canadian Thoracic Society clinical practice guideline. (2012) (95)
Living with chronic obstructive pulmonary disease: a survey of patients' knowledge and attitudes. (2009) (89)
Prevention of Acute Exacerbations of COPD (2015) (70)
Tiotropium in Combination with Placebo, Salmeterol, or Fluticasone–Salmeterol for Treatment of Chronic Obstructive Pulmonary Disease A Randomized Trial (2007) (63)
Asthma worsenings: approaches to prevention and management from the Asthma Worsenings Working Group. (2008) (62)
Executive summary: prevention of acute exacerbation of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline. (2015) (60)
Cocaine induced eosinophilic lung disease. (1992) (59)
Canadian guidelines for the management of acute exacerbations of chronic bronchitis: executive summary. (2003) (59)
CTS position statement: Pharmacotherapy in patients with COPD—An update (2017) (53)
Canadian Thoracic Society Clinical Practice Guideline on pharmacotherapy in patients with COPD – 2019 update of evidence (2019) (50)
Diagnosis of asthma in adults (2009) (41)
Canadian practice assessment in chronic obstructive pulmonary disease: respiratory specialist physician perception versus patient reality. (2013) (41)
Nontuberculous mycobacterial infection as a cause of difficult-to-control asthma: a case-control study. (2011) (35)
[Canadian Thoracic Society COPD guidelines: summary of highlights for family doctors]. (2003) (33)
Correlation of late gadolinium enhancement MRI and quantitative T2 measurement in cardiac sarcoidosis (2014) (33)
The Canadian Optimal Therapy of COPD Trial: design, organization and patient recruitment. (2004) (28)
Treatment of allergic bronchopulmonary aspergillosis with inhaled corticosteroids. (1992) (26)
Albuterol via Turbuhaler versus albuterol via pressurized metered-dose inhaler in asthma. (1997) (22)
Diffuse panbronchiolitis in a Caucasian man in Canada. (2003) (21)
Inhaled beclomethasone dipropionate improves acoustic measures of voice in patients with asthma. (2001) (20)
Development of a patient-centred, evidence-based and consensus-based discharge care bundle for patients with acute exacerbation of chronic obstructive pulmonary disease (2018) (19)
Asthma and allergy avoidance knowledge and behavior in postpartum women. (1997) (18)
Management of asthma in adults (2009) (17)
Epidemiology and health outcomes of sarcoidosis in a universal healthcare population: a cohort study (2019) (16)
Diagnostic Accuracy of Cardiac MRI versus FDG PET for Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis. (2022) (15)
Combined simultaneous FDG-PET/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosis (2021) (15)
Search for Chronic Beryllium Disease Among Sarcoidosis Patients in Ontario, Canada (2011) (14)
Acute lung injury during antithymocyte globulin therapy for aplastic anemia. (2009) (14)
Zileuton added to low-dose inhaled beclomethasone for the treatment of moderate to severe persistent asthma. (2007) (14)
Erythropoietin response to acute hypoxemia in patients with chronic pulmonary disease. (1992) (12)
Chronic Obstructive Pulmonary Disease: A palliative medicine review of the disease, its therapies and drug interactions. (2020) (9)
Rapid pulmonary phospholipid accumulation induced by intravenous amiodarone. (1993) (8)
The impact of demographic disparities in the presentation of sarcoidosis: A multicenter prospective study. (2021) (7)
Management of chronic bronchitis and acute exacerbations of chronic bronchitis. (1997) (7)
Treating acute exacerbations of chronic bronchitis and community-acquired pneumonia: how effective are respiratory fluoroquinolones? (2006) (5)
Hypersensitivity pneumonitis with normal high resolution computed tomography scans. (2001) (5)
Thoracic actinomycosis in a patient with pulmonary involvement caused by non-Hodgkin's lymphoma. (1996) (5)
Clinical Trial Risk in Chronic Obstructive Pulmonary Disease: The Effects of Drug Class and Inclusion Criteria (2015) (4)
Clinical problem-solving. Under pressure. (2010) (3)
Hospitalizations in Sarcoidosis: A Cohort Study of a Universal Health Care Population (2020) (3)
Effects of oxygen withdrawal on catecholamine release in patients on home oxygen therapy. (1990) (3)
OBSTETRIC PATIENTS IN THE INTENSIVE CARE UNIT (1994) (3)
Myocardial extracellular space volume in patients with systemic sarcoidosis: quantitative measurement using a T1 mapping technique (2014) (3)
Cavitary aspergillosis as a complication of AIDS. (1993) (2)
[Canadian Thoracic Society COPD guidelines: summary of highlights for family doctors]. (2003) (2)
Cardiac Sarcoidosis: A Clinical Overview. (2021) (1)
Non Tuberculous Mycobacterial (NTM) Infection as a Cause for Difficult to Control Asthma: A Case Control Study. (2009) (1)
Canadian Thoracic Society COPD Guidelines: summary of highlights for family doctors. (2003) (1)
Corrigendum to “Living with chronic obstructive pulmonary disease: A survey of patients' knowledge and attitudes” [Respiratory Medicine 103 (2009) 1004–1012] (2009) (1)
Treatment of the recalcitrant asthmatic. (1989) (1)
Respirologists' perception versus patient reality: A Canadian perspective on COPD (2011) (0)
Hospitalizations in Sarcoidosis: A Cohort Study of a Universal Health Care Population. (2021) (0)
Haemophilus influenzae abscess presenting as an asymptomatic lung mass. (1990) (0)
Nontubercular Mycobacterial Pulmonary Infection in Severe Asthma: Response (2011) (0)
Ophthalmology Evaluations of Patients with Sarcoidosis Living in Ontario, Canada (2020) (0)
Treating airway inflammation (1996) (0)
Prognosis in a patient with an initial normal pulmonary angiogram. (1994) (0)
FDA approves return of Primatene Mist (2018) (0)
THE 2005 ASTHMA ACTION STUDY IN CANADA (2005) (0)
Ophthalmologic assessments in patients with newly diagnosed sarcoidosis: An observational study from a universal healthcare system. (2021) (0)
Ophthalmologic Assessments in Patients with Newly Diagnosed Sarcoidosis: An Observational Study from a Universal Healthcare System (0)
Comparison Of COPD Disability Impact In Elderly Patients In Canada And Italy (2010) (0)
Gaps in Reaching the Goal of Optimal COPD Management: Results of a Canadian Parallel Survey for Family Physicians and COPD Patients; the Exacerbation Prevention in Canada Program (2016) (0)
Prognostic Value of Cardiac MRI and FDG PET in Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis. (2023) (0)
Just the berries. Management of community-acquired pneumonia. Evidence-based update. (2002) (0)
The Prevalence of Chronic Beryllium Disease among Sarcoidosis Patients in Ontario. (2009) (0)
of COPD in randomised controlled trials Counting, analysing and reporting exacerbations (2008) (0)
Epidemiology and Survival of Systemic Sclerosis–Sarcoidosis Overlap Syndrome (2023) (0)
Quantitative myocardial T2 measurement for systemic sarcoidosis with cardiac involvement: initial results (2011) (0)
Acute Exacerbations of COPD - Pulmonologist's Perceptions Versus COPD Patient's Reality (2011) (0)
14 Asthma in Pregnancy (2022) (0)
134 MRI Detection and Quantitative T2 Measurement of Cardiac Involvement in Systemic Sarcoidosis: Initial Results (2012) (0)

This paper list is powered by the following services:

Other Resources About Meyer Balter

en.wikipedia.org

What Schools Are Affiliated With Meyer Balter?

Meyer Balter is affiliated with the following schools:

University of Toronto